Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells

J Immunol. 2013 Sep 1;191(5):2708-16. doi: 10.4049/jimmunol.1301138. Epub 2013 Aug 5.

Abstract

CMV infection represents a major complication in hematopoietic stem cell transplantation, which compromises graft outcome. Downregulation of HLA class I expression is one mechanism by which CMV evades T cell-mediated immune detection, rendering infected cells vulnerable to killer cell Ig-like receptor (KIR)(+) NK cells. In this study, we observed that the amplified NKG2C(+) NK cell population observed specifically in CMV seropositive individuals mainly expressed KIR2DL receptors. We have shown that HLA class I expression was downregulated on CMV-infected immature dendritic cells (iDCs), which escape to HLA-A2-pp65-specific T lymphocytes but strongly trigger the degranulation of KIR2D(+) NK cells. CMV infection conferred a vulnerability of C2C2(+) iDCs to educated KIR2DL1(+) and KIR2DL3(+) NK cell subsets. Alloreactivity of KIR2DL1(+) NK cell subsets against C1C1(+) iDCs was maintained independently of CMV infection. Unexpectedly, CMV-infected C1C1(+) iDCs did not activate KIR2DL3(+) NK cell reactivity, suggesting a potential CMV evasion to KIR2DL3 NK cell recognition. Altogether, the coexpression of KIR and NKG2C on expanded NK cell subsets could be related to a functional contribution of KIR in CMV infection and should be investigated in hematopoietic stem cell transplantation, in which the beneficial impact of CMV infection has been reported on the graft-versus-leukemia effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytomegalovirus Infections / immunology*
  • Cytomegalovirus Infections / metabolism
  • Dendritic Cells / immunology
  • Dendritic Cells / virology*
  • Flow Cytometry
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / metabolism
  • NK Cell Lectin-Like Receptor Subfamily C / immunology*
  • NK Cell Lectin-Like Receptor Subfamily C / metabolism
  • Receptors, KIR / biosynthesis*
  • Receptors, KIR / immunology
  • Receptors, KIR2DL1 / biosynthesis
  • Receptors, KIR2DL1 / immunology
  • Receptors, KIR2DL3 / biosynthesis
  • Receptors, KIR2DL3 / immunology

Substances

  • Histocompatibility Antigens Class I
  • KIR2DL1 protein, human
  • KIR2DL3 protein, human
  • KLRC2 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C
  • Receptors, KIR
  • Receptors, KIR2DL1
  • Receptors, KIR2DL3